Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Julphar
Deloitte
McKinsey
Chubb
Chinese Patent Office
Daiichi Sankyo
Cerilliant
Healthtrust

Generated: January 23, 2018

DrugPatentWatch Database Preview

PRAZOSIN HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prazosin hydrochloride and what is the scope of prazosin hydrochloride patent protection?

Prazosin hydrochloride
is the generic ingredient in three branded drugs marketed by Pfizer, Am Therap, Dava Pharms Inc, Idt Australia Ltd, Mylan, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for prazosin hydrochloride. Fourteen suppliers are listed for this compound.
Pharmacology for PRAZOSIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PRAZOSIN HYDROCHLORIDE

US Patents and Regulatory Information for PRAZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072352-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Am Therap PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072782-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Am Therap PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072784-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dava Pharms Inc PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072705-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 071745-001 Sep 12, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072575-002 May 16, 1989 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072992-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072921-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Am Therap PRAZOSIN HYDROCHLORIDE prazosin hydrochloride CAPSULE;ORAL 072783-001 May 16, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PRAZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer MINIPRESS XL prazosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 019775-002 Jan 29, 1992 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS XL prazosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 019775-001 Jan 29, 1992 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS XL prazosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 019775-001 Jan 29, 1992 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS XL prazosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 019775-002 Jan 29, 1992 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS XL prazosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 019775-001 Jan 29, 1992 ➤ Subscribe ➤ Subscribe
Pfizer MINIPRESS prazosin hydrochloride CAPSULE;ORAL 017442-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
QuintilesIMS
Johnson and Johnson
Teva
AstraZeneca
Accenture
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot